Available extracorporeal treatments for poisoning: Overview and limitations

Seminars in Dialysis

Volumn 27, Issue 4, 2014, Pages 342-349

  Ouellet, Georges ^a   Bouchard, Josée ^b   Ghannoum, Marc ^c   Decker, Brian Scott ^d  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXTRACORPOREAL OXYGENATION; HUMAN; INTOXICATION; PROCEDURES; RENAL REPLACEMENT THERAPY; THERAPY;

EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; POISONING; RENAL REPLACEMENT THERAPY;

EID: 84904056728     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12238     Document Type: Article

References (121)

1. Mowry JB, Spyker DA, Cantilena LR Jr, Bailey JE, Ford M: 2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report. Clin Toxicol (Phila) 51:949-1229, 2013
2. Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS: Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int 74:1327-1334, 2008
3. Shannon MW: Comparative efficacy of hemodialysis and hemoperfusion in severe theophylline intoxication. Acad Emerg Med 4:674-678, 1997
4. Tyagi PK, Winchester JF, Feinfeld DA: Extracorporeal removal of toxins. Kidney Int 74:1231-1233, 2008
5. Kan G, Jenkins I, Rangan G, Woodroffe A, Rhodes H, Joyce D: Continuous haemodiafiltration compared with intermittent haemodialysis in the treatment of methanol poisoning. Nephrol Dial Transplant 18:2665-2667, 2003
6. Ghannoum M, Roberts DM, Hoffman RS, Ouellet G, Roy L, Decker BS, Bouchard J: A stepwise approach for the management of poisoning with extracorporeal treatments. Semin Dial ???:???-???, ???? this issue
7. Ghannoum M, Troyanov S, Ayoub P, Lavergne V, Hewlett T: Successful hemodialysis in a phenytoin overdose: case report and review of the literature. Clin Nephrol 74:59-64, 2010
8. Ozhasenekler A, Gokhan S, Guloglu C, Orak M, Ustundag M: Benefit of hemodialysis in carbamazepine intoxications with neurological complications. Eur Rev Med Pharmacol Sci 16(Suppl. 1):43-47, 2012
9. Tapolyai M, Campbell M, Dailey K, Udvari-Nagy S: Hemodialysis is as effective as hemoperfusion for drug removal in carbamazepine poisoning. Nephron 90:213-215, 2002
10. Dorval M, Pichette V, Cardinal J, Geadah D, Ouimet D, Leblanc M: The use of an ethanol- and phosphate-enriched dialysate to maintain stable serum ethanol levels during haemodialysis for methanol intoxication. Nephrol Dial Transplant 14:1774-1777, 1999
11. Bouchard J, Roberts DM, Roy L, Ouellet G, Decker BS, Mueller BA, Desmeules S, Ghannoum M: Principles and operational parameters to optimize poison removal with extracorporeal treatments. Semin Dial ???:???-???, ???? this issue
12. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K112314
13. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W: A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 11:2344-2350, 2000
14. Ahrenholz PG, Winkler RE, Michelsen A, Lang DA, Bowry SK: Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: the beta2-microglobulin/albumin relationship. Clin Nephrol 62:21-28, 2004
15. Maduell F, del Pozo C, Garcia H, Sanchez L, Hdez-Jaras J, Albero MD, Calvo C, Torregrosa I, Navarro V: Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant 14:1202-1207, 1999
16. Yamashita AC: Mechanisms of solute and fluid removal in hemodiafiltration. Contrib Nephrol 158:50-56, 2007
17. Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK: Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 69:2087-2093, 2006
18. Pedrini LA, De Cristofaro V, Comelli M, Casino FG, Prencipe M, Baroni A, Campolo G, Manzoni C, Coli L, Ruggiero P, Acquistapace I, Auriemma L: Long-term effects of high-efficiency on-line haemodiafiltration on uraemic toxicity. A multicentre prospective randomized study. Nephrol Dial Transplant 26:2617-2624, 2011
19. Troyanov S, Cardinal J, Geadah D, Parent D, Courteau S, Caron S, Leblanc M: Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters. Nephrol Dial Transplant 18:961-966, 2003
20. Maduell F, Navarro V, Cruz MC, Torregrosa E, Garcia D, Simon V, Ferrero JA: Osteocalcin and myoglobin removal in on-line hemodiafiltration versus low- and high-flux hemodialysis. Am J Kidney Dis 40:582-589, 2002
21. Bailey AR, Sathianathan VJ, Chiew AL, Paterson AD, Chan BS, Arora S: Comparison of intermittent haemodialysis, prolonged intermittent renal replacement therapy and continuous renal replacement haemofiltration for lithium toxicity: a case report. Crit Care Resusc 13:120-122, 2011
22. Kim Z, Goldfarb DS: Continuous renal replacement therapy does not have a clear role in the treatment of poisoning. Nephron Clin Pract 115:c1-c6, 2010
23. Harder JL, Heung M, Vilay AM, Mueller BA, Segal JH: Carbamazepine and the active epoxide metabolite are effectively cleared by hemodialysis followed by continuous venovenous hemodialysis in an acute overdose. Hemodial Int 15:412-415, 2011
24. Mendonca S, Gupta S, Gupta A: Extracorporeal management of poisonings. Saudi J Kidney Dis Transpl 23:1-7, 2012
25. Thanacoody RH: Extracorporeal elimination in acute valproic acid poisoning. Clin Toxicol (Phila) 47:609-616, 2009
26. Marshall MR: Dialytic management of acute kidney injury and intensive care unit nephrology. In: Floege JJR, Feehally J (eds). Comprehensive Clinical Nephrology, 4th edn. Elsevier Saunders Company: St. Louis, 2010:843-852
27. Fiaccadori E, Maggiore U, Parenti E, Greco P, Cabassi A: Sustained low-efficiency dialysis (SLED) for acute lithium intoxication. Nephrol Dial Transplant 24:329-332, 2008
28. Berbece AN, Richardson RM: Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal. Kidney Int 70:963-968, 2006
29. Liao Z, Zhang W, Hardy PA, Poh CK, Huang Z, Kraus MA, Clark WR, Gao D: Kinetic comparison of different acute dialysis therapies. Artif Organs 27:802-807, 2003
30. Lund B, Seifert SA, Mayersohn M: Efficacy of sustained low-efficiency dialysis in the treatment of salicylate toxicity. Nephrol Dial Transplant 20:1483-1484, 2005
31. Khan E, Huggan P, Celi L, MacGinley R, Schollum J, Walker R: Sustained low-efficiency dialysis with filtration (SLEDD-f) in the management of acute sodium valproate intoxication. Hemodial Int 12:211-214, 2008
32. Wu CL, Chiu PF, Yang Y, Wen YK, Chiu CC, Chang CC: Sustained low-efficiency daily diafiltration with hemoperfusion as a therapy for severe star fruit intoxication: a report of two cases. Ren Fail 33:837-841, 2011
33. Treysman L, Meehan TJ, Schlieben DJ, Ducre B, Erickson TB: Pharmacokinetic modeling of lithium elimination during 67 continuous hours of high flux hemodialysis (abstract). Clin Toxicol 48:647, 2010
34. Amdisen A: Serum level monitoring and clinical pharmacokinetics of lithium. Clin Pharmacokinet 2:73-92, 1977
35. Goodman JW, Goldfarb DS: The role of continuous renal replacement therapy in the treatment of poisoning. Semin Dial 19:402-407, 2006
36. Ghannoum M, Bouchard J, Nolin TD, Ouellet G, Roberts DM: Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance and application in clinical practice. Semin Dial ???:???-???, ???? this issue
37. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH: Apheresis Applications Committee of the American Society for A. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 25:83-177, 2010
38. Schutt RC, Ronco C, Rosner MH: The role of therapeutic plasma exchange in poisonings and intoxications. Semin Dial 25:201-206, 2012
39. Jones JS, Dougherty J: Current status of plasmapheresis in toxicology. Ann Emerg Med 15:474-482, 1986
40. Okafor C, Kalantarinia K: Vascular access considerations for therapeutic apheresis procedures. Semin Dial 25:140-144, 2012
41. Schonermarck U, Bosch T: Vascular access for apheresis in intensive care patients. Ther Apher Dial 7:215-220, 2003
42. Tan HK, Hart G: Plasma filtration. Ann Acad Med Singapore 34:615-624, 2005
43. Ibrahim RB, Liu C, Cronin SM, Murphy BC, Cha R, Swerdlow P, Edwards DJ: Drug removal by plasmapheresis: an evidence-based review. Pharmacotherapy 27:1529-1549, 2007
44. Lambert C, Gericke M, Smith R, Hermans C: Plasma extraction rate and collection efficiency during therapeutic plasma exchange with Spectra Optia in comparison with Haemonetics MCS+ [Article]. J Clin Apher 26:17-22, 2011
45. Kaplan AA, Bailey RA, Kew CE, Reardon J, Sevigny J: High flux plasma exchange using a modified rotating membrane system. ASAIO J 42:957-960, 1996
46. Madore F: Plasmapheresis technical aspects and indications. Crit Care Clin 18(2):375-392, 2002
47. Shelat SG: Practical considerations for planning a therapeutic apheresis procedure. Am J Med 123:777-784, 2010
48. Solomon A, Fahey JL: Plasmapheresis therapy in macroglobulinemia. Ann Intern Med 58:789-800, 1963
49. Fahey JL, Barth WF, Solomon A: Serum hyperviscosity syndrome. JAMA 192:464-467, 1965
50. Chu G, Mantin R, Shen YM, Baskett G, Sussman H: Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management. Cancer 72:3707-3714, 1993
51. Pierga JY, Beuzeboc P, Dorval T, Palangie T, Pouillart P: Favourable outcome after plasmapheresis for vincristine overdose. Lancet 340:185, 1992
52. Kuhlmann U, Schoenemann H, Muller T, Keuchel M, Lange H: Plasmapheresis in life-threatening verapamil intoxication. Artif Cells Blood Substit Immobil Biotechnol 28:429-440, 2000
53. Gambi D, Oggioni R, Mangani V, Librenti M, Manescalchi F, Tulli G: [Acute carbamazepine poisoning treated with plasmapheresis. Description of a clinical case]. Minerva Anestesiol 59:547-552, 1993
54. Talbert RL, Wong YY, Duncan DB: Propranolol plasma concentrations and plasmapheresis. Drug Intell Clin Pharm 15:993-996, 1981
55. Jha S, Waghdhare S, Reddi R, Bhattacharya P: Thyroid storm due to inappropriate administration of a compounded thyroid hormone preparation successfully treated with plasmapheresis. Thyroid 22:1283-1286, 2012
56. Jander S, Bischoff J, Woodcock BG: Plasmapheresis in the treatment of Amanita phalloides poisoning: II. A review and recommendations. Ther Apher 4:308-312, 2000
57. Krisper P, Stauber RE: Technology insight: artificial extracorporeal liver support-how does Prometheus compare with MARS? Nat Clin Pract Nephrol 3:267-276, 2007
58. Krisper P, Stadlbauer V, Stauber RE: Clearing of toxic substances: are there differences between the available liver support devices? Liver Int 31(Suppl. 3):5-8, 2011
59. Karvellas CJ, Gibney N, Kutsogiannis D, Wendon J, Bain VG: Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure. Crit Care 11:215, 2007
60. Wittebole X, Hantson P: Use of the molecular adsorbent recirculating system (MARS?) for the management of acute poisoning with or without liver failure. Clin Toxicol (Phila) 49:782-793, 2011
61. Rifai K: Extracorporeal albumin dialysis. Hepatol Res 38(Suppl. 1):S41-S45, 2008
62. Sen S, Ratnaraj N, Davies NA, Mookerjee RP, Cooper CE, Patsalos PN, Williams R, Jalan R: Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Epilepsia 44:265-267, 2003
63. Askenazi DJ, Goldstein SL, Chang IF, Elenberg E, Feig DI: Management of a severe carbamazepine overdose using albumin-enhanced continuous venovenous hemodialysis. Pediatrics 113:406-409, 2004
64. Korsheed S, Selby NM, Fluck RJ: Treatment of severe theophylline poisoning with the molecular adsorbent recirculating system (MARS). Nephrol Dial Transplant 22:969-970, 2007
65. Pichon N, Dugard A, Clavel M, Amiel JB, Francois B, Vignon P: Extracorporeal albumin dialysis in three cases of acute calcium channel blocker poisoning with life-threatening refractory cardiogenic shock. Ann Emerg Med 59:540-544, 2012
66. Vilay AM, Mueller BA, Haines H, Alten JA, Askenazi DJ: Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase. Pharmacotherapy 30:111, 2010
67. Evenepoel P, Laleman W, Wilmer A, Claes K, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y: Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Artif Organs 30:276-284, 2006
68. Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, Noldge-Schomburg G: Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am SocNephrol 12(Suppl. 17):S75-S82, 2001
69. Stadlbauer V, Krisper P, Aigner R, Haditsch B, Jung A, Lackner C, Stauber RE: Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care 10:R169, 2006
70. Stadlbauer V, Krisper P, Beuers U, Haditsch B, Schneditz D, Jung A, Putz-Bankuti C, Holzer H, Trauner M, Stauber RE: Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure. ASAIO J 53:187-193, 2007
71. Krisper P, Haditsch B, Stauber R, Jung A, Stadlbauer V, Trauner M, Holzer H, Schneditz D: In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 43:451-457, 2005
72. Drexler K, Baustian C, Richter G, Ludwig J, Ramlow W, Mitzner S: Albumin dialysis molecular adsorbents recirculating system: impact of dialysate albumin concentration on detoxification efficacy. Ther Apher Dial 13:393-398, 2009
73. Weiler S, Vogelsinger H, Joannidis M, Dunzendorfer S, Bellmann R: Influence of albumin dialysis on pharmacokinetics of amphotericin B colloidal dispersion and amphotericin B lipid complex. [Miscellaneous Article].. Artifi Organs 35:667-671, 2011
74. Churchwell MD, Pasko DA, Smoyer WE, Mueller BA: Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis. Nephrol Dial Transplant 24:231-238, 2009
75. Dichtwald S, Dahan E, Adi N, Moses A, Sorkine P: Molecular adsorbent recycling system therapy in the treatment of acute valproic acid intoxication. Israel Med Assoc J 12(5):307-308, 2010
76. Manley HJ, Bridwell DL, Elwell RJ, Bailie GR: Influence of peritoneal dialysate flow rate on the pharmacokinetics of cefazolin. Perit Dial Int 23:469-474, 2003
77. Lee CS, Peterson JC, Marbury TC: Comparative pharmacokinetics of theophylline in peritoneal dialysis and hemodialysis. J Clin Pharmacol 23:274-280, 1983
78. Pond SM: Extracorporeal techniques in the treatment of poisoned patients. Med J Aust 154:617-622, 1991
79. Fertel BS, Nelson LS, Goldfarb DS: Extracorporeal removal techniques for the poisoned patient: a review for the intensivist. J Intensive Care Med 25:139-148, 2010
80. Shinaberger JH, Shear L, Clayton LE, Barry KG, Knowlton M, Goldbaum LR: Dialysis for intoxication with lipid soluble drugs: enhancement of glutethimide extraction with lipid dialysate. Trans Am Soc Artif Intern Organs 11:173-177, 1965
81. Amerling R, Glezerman I, Savransky E, Dubrow A, Ronco C: Continuous flow peritoneal dialysis: principles and applications. Semin Dial 16:335-340, 2003
82. Charen E, Dadzie K, Sheth N, Siktel H, Dubrow A, Harbord N, Winchester J, Ronco C, Amerling R: Hepatorenal syndrome treated for eight months with continuous-flow peritoneal dialysis. Adv Perit Dial 29:38-42, 2013
83. Leypoldt JK, Burkart JM: Small-solute and middle-molecule clearances during continuous flow peritoneal dialysis. Adv Perit Dial 18:26-31, 2002
84. Freida P, Issad B: Continuous flow peritoneal dialysis: assessment of fluid and solute removal in a high-flow model of "fresh dialysate single pass". Perit Dial Int 23:348-355, 2003
85. Szepietowski T, Weyde W, Stefanska-Bac E: Methanol elimination in peritoneal dialysis [Polish]. Pol Tyg Lek 30(22):933-935, 1975
86. Romeo L, Apostoli P, Kovacic M, Martini S, Brugnone F: Acute arsine intoxication as a consequence of metal burnishing operations. Am J Ind Med 32:211-216, 1997
87. Leitner GC, Hiesmayr M, Hoecker P, Jilma B: Therapeutic approaches in the management of oral cyclosporine A intoxication. Transplantation 75:1764-1765, 2003
88. Kwon SU, Lim SH, Rhee I, Kim SW, Kim JK, Kim DW, Jeon ES: Successful whole blood exchange by apheresis in a patient with acute cyclosporine intoxication without long-term sequelae. J Heart Lung Transplant 25(4):483-485, 2006
89. Moorman MT, Epstein RB, Smith JW, O'Neal C, Holter JL: Management of cyclosporine overdose in a hematopoietic stem cell transplant patient with sequential plasma exchange and red blood cell exchange. J Clin Apher 26:156-158, 2011
90. McCarthy H, Inward C, Marriage S, Astley P, Tizard EJ: Red cell exchange transfusion as a rescue therapy for tacrolimus toxicity in a paediatric renal transplant. Pediatr Nephrol 26:2245-2248, 2011
91. Roberts DM, Heilmair R, Buckley NA, Dawson AH, Fahim M, Eddleston M, Eyer P: Clinical outcomes and kinetics of propanil following acute self-poisoning: a prospective case series. BMC Clin Pharmacol 9:3, 2009
92. Mier RJ: Treatment of aniline poisoning with exchange transfusion. J Toxicol Clin Toxicol 26(5-6):357-364, 1988
93. Southgate HJ, Masterson R: Lessons to be learned: a case study approach: prolonged methaemoglobinaemia due to inadvertent dapsone poisoning; Treatment with methylene blue and exchange transfusion. J R Soc Promot Health 119(1):52-55, 1999
94. Kirby NG: Sodium-nitrite poisoning treated by exchange transfusion. Lancet 268(6864):594-595, 1955
95. Manikian A, Stone S, Hamilton R, Foltin G, Howland MA, Hoffman RS: Exchange transfusion in severe infant salicylism. Vet Hum Toxicol 44:224-227, 2002
96. Osborn HH, Henry G, Wax P, Hoffman R, Howland MA: Theophylline toxicity in a premature neonate-elimination kinetics of exchange transfusion. J Toxicol Clin Toxicol 31:639-644, 1993
97. Sancak R, Kucukoduk S, Tasdemir HA, Belet N: Exchange transfusion treatment in a newborn with phenobarbital intoxication. Pediatr Emerg Care 15:268-270, 1999
98. Finkelstein Y, Zevin S, Raikhlin-Eisenkraft B, Bentur Y: Intrathecal methotrexate neurotoxicity: clinical correlates and antidotal treatment. Environ Toxicol Pharmacol 19:721-725, 2005
99. Jardine LF, Ingram LC, Bleyer WA: Intrathecal leucovorin after intrathecal methotrexate overdose. J Pediatr Hematol Oncol 18:302-304, 1996
100. Widemann BC, Balis FM, Shalabi A, Boron M, O'Brien M, Cole DE, Jayaprakash N, Ivy P, Castle V, Muraszko K, Moertel CL, Trueworthy R, Hermann RC, Moussa A, Hinton S, Reaman G, Poplack D, Adamson PC: Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst 96:1557-1559, 2004
101. Ettinger LJ: Pharmacokinetics and biochemical effects of a fatal intrathecal methotrexate overdose. Cancer 50:444-450, 1982
102. Kristof RA, Clusmann H, Koehler W, Fink KB, Schramm J: Treatment of accidental high dose intraventricular mezlocillin application by cerebrospinal fluid exchange. J Neurol Neurosurg Psychiatry 64:379-381, 1998
103. Johnson NJ, Gaieski DF, Allen SR, Perrone J, DeRoos F: A review of emergency cardiopulmonary bypass for severe poisoning by cardiotoxic drugs. J Med Toxicol 9:54-60, 2013
104. de Lange DW, Sikma MA, Meulenbelt J: Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clin Toxicol (Phila) 51:385-393, 2013
105. Banner W Jr: Risks of extracorporeal membrane oxygenation: is there a role for use in the management of the acutely poisoned patient? J Toxicol Clin Toxicol 34:365-371, 1996
106. Hendren WG, Schieber RS, Garrettson LK: Extracorporeal bypass for the treatment of verapamil poisoning. Ann Emerg Med 18:984-987, 1989
107. Babatasi G, Massetti M, Verrier V, Lehoux P, Le Page O, Bruno PG, Khayat A: [Severe intoxication with cardiotoxic drugs: value of emergency percutaneous cardiocirculatory assistance]. Arch Mal Coeur Vaiss 94:1386-1392, 2001
108. Durward A, Guerguerian AM, Lefebvre M, Shemie SD: Massive diltiazem overdose treated with extracorporeal membrane oxygenation. Pediatr Crit Care Med 4:372-376, 2003
109. Holzer M, Sterz F, Schoerkhuber W, Behringer W, Domanovits H, Weinmar D, Weinstabl C, Stimpfl T: Successful resuscitation of a verapamil-intoxicated patient with percutaneous cardiopulmonary bypass. Crit Care Med 27:2818-2823, 1999
110. Maclaren G, Butt W, Cameron P, Preovolos A, McEgan R, Marasco S: Treatment of polypharmacy overdose with multimodality extracorporeal life support. Anaesth Intensive Care 33:120-123, 2005
111. Masson R, Colas V, Parienti JJ, Lehoux P, Massetti M, Charbonneau P, Saulnier F, Daubin C: A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation 83:1413-1417, 2012
112. Bilbault P, Pynn S, Mathien C, Mazzucotelli JP, Schneider F, Jaeger A: Near-fatal betaxolol self-poisoning treated with percutaneous extracorporeal life support. Eur J Emerg Med 14:120-122, 2007
113. Rooney M, Massey KL, Jamali F, Rosin M, Thomson D, Johnson DH: Acebutolol overdose treated with hemodialysis and extracorporeal membrane oxygenation. J Clin Pharmacol 36:760-763, 1996
114. Scalzo AJ, Weber TR, Jaeger RW, Connors RH, Thompson MW: Extracorporeal membrane oxygenation for hydrocarbon aspiration. Am J Dis Child 144:867-871, 1990
115. Chyka PA: Benefits of extracorporeal membrane oxygenation for hydrocarbon pneumonitis. J Toxicol Clin Toxicol 34:357-363, 1996
116. Bille AB, Pedersen KD, Hertel S: [Extracorporeal membrane oxygenation of a child with severe chemical pneumonia]. Ugeskr Laeger 173:3115-3116, 2011
117. Goodwin DA, Lally KP, Null DM Jr: Extracorporeal membrane oxygenation support for cardiac dysfunction from tricyclic antidepressant overdose. Crit Care Med 21:625-627, 1993
118. Williams JM, Hollingshed MJ, Vasilakis A, Morales M, Prescott JE, Graeber GM: Extracorporeal circulation in the management of severe tricyclic antidepressant overdose. Am J Emerg Med 12:456-458, 1994
119. Megarbane B, Leprince P, Deye N, Guerrier G, Resiere D, Bloch V, Baud FJ: Extracorporeal life support in a case of acute carbamazepine poisoning with life-threatening refractory myocardial failure. Intensive Care Med 32:1409-1413, 2006
120. Riou B, Barriot P, Rimailho A, Baud FJ: Treatment of severe chloroquine poisoning. N Engl J Med 318:1-6, 1988
121. Bunchman TE, Ferris ME: Management of toxic ingestions with the use of renal replacement therapy. Pediatr Nephrol 26:535-541, 2011